DANZITEN vs NINTEDANIB

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. DANZITEN and NINTEDANIB are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	NINTEDANIB
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	NINTEDANIB
Manufacturer	Azurity	Teva Pharmaceuticals Development Inc
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Idiopathic Pulmonary Fibrosis

danziten nintedanib

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

NILOTINIB TARTRATE

NINTEDANIB

Manufacturer

Azurity

Teva Pharmaceuticals Development Inc

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Idiopathic Pulmonary Fibrosis

Frequently asked questions

What is the difference between Danziten and Nintedanib?

Danziten contains Nilotinib Tartrate, while Nintedanib contains Nintedanib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.